DarioHealth Corp.DRIONASDAQ

Overview Intelligence Charts News Fundamentals

Analyst Sentiment

Analysts lean bullish — 100% recommend buying.

Consensus Rating

Buy

8 analysts·Limited coverage

100%

Rating Distribution

Strong Buy

00%

Buy

8100%

Hold

00%

Sell

00%

Strong Sell

00%

Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.

Price Target Expectations

Analysts see significant upside — consensus target 55% higher.

Bear Case

$16.00

+55%

Consensus

$16.00

+55%

Bull Case

$16.00

+55%

Price Range8 analysts

Low

Consensus

High

$16.00

Current Target

Current Price

$10.30

Upside to Target

$5.70

Price targets are 12-month forecasts. Actual results depend on earnings, market conditions, and sector trends.

Earnings & Revenue Estimates

2026E$-8.56(3 analysts)

Actual

Estimate

Range (Low–High)

Stock Alarm Pro

Forward Growth Estimates (YoY)

FY2027

Rev+22.18%

EPS—

FY2028

Rev+11.57%

EPS—

FY2029

Rev+19.54%

EPS—

Earnings Surprises

Beat rate:83%(10/12 quarters)

Avg surprise:+48.6%

Beat

Miss

Inline

Estimate

Based on reported EPS vs consensus estimate.

Recent Analyst Actions

Nov 14, 2025Stifel Nicolaus

DarioHealth Corp. (DRIO) PT Raised to $16 at Stifel Following 20-1 Stock Split

Target:$16.00

+50.8%from $10.61

Nov 16, 2022Industrial Alliance Securities

Alliance Global Partners Maintains Buy on DarioHealth, Lowers Price Target to $7.5

Target:$7.50

+44.8%from $5.18

Aug 18, 2022Cowen & Co.

Cowen & Co. Maintains Outperform on DarioHealth, Lowers Price Target to $14

Target:$14.00

+155.0%from $5.49

May 16, 2022Cowen & Co.

Cowen & Co. Maintains Outperform on DarioHealth, Raises Price Target to $18

Target:$18.00

+184.4%from $6.33

Explore More

S&P 500 Screener

Filter and sort all 500 stocks

Market Movers

Today's biggest gainers and losers

Market Heatmap

Visual sector performance